121 related articles for article (PubMed ID: 21536921)
1. Photocytotoxicity of hypocrellin B (HB) was enhanced by liposomalization in vitro.
Zhou Z; Zhang L; Liu H; Zhang Q; Liu B; Ai P; Ma H; Liu W; Li Z; Sheng W; Zeng Y; Zhong R
Int J Toxicol; 2011 Mar; 30(2):174-80. PubMed ID: 21536921
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
3. Interactive transport, subcellular relocation and enhanced phototoxicity of hypericin encapsulated in guanidinylated liposomes via molecular recognition.
Galanou MC; Theodossiou TA; Tsiourvas D; Sideratou Z; Paleos CM
Photochem Photobiol; 2008; 84(5):1073-83. PubMed ID: 18627515
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy.
Wang ZJ; He YY; Huang CG; Huang JS; Huang YC; An JY; Gu Y; Jiang LJ
Photochem Photobiol; 1999 Nov; 70(5):773-80. PubMed ID: 10568169
[TBL] [Abstract][Full Text] [Related]
5. Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo.
Li T; Hou X; Deng H; Zhao J; Huang N; Zeng J; Chen H; Gu Y
Photochem Photobiol Sci; 2015 May; 14(5):972-81. PubMed ID: 25793654
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of hypocrellin pharmacokinetics in phototherapy.
Ali SM; Olivo M
Int J Oncol; 2002 Dec; 21(6):1229-37. PubMed ID: 12429972
[TBL] [Abstract][Full Text] [Related]
7. Development of copolymeric nanoparticles of hypocrellin B: Enhanced phototoxic effect and ocular distribution.
Krishnaswami V; Ponnusamy C; Sankareswaran S; Paulsamy M; Madiyalakan R; Palanichamy R; Kandasamy R; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():26-36. PubMed ID: 29055734
[TBL] [Abstract][Full Text] [Related]
8. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes.
Gijsens A; Derycke A; Missiaen L; De Vos D; Huwyler J; Eberle A; de Witte P
Int J Cancer; 2002 Sep; 101(1):78-85. PubMed ID: 12209592
[TBL] [Abstract][Full Text] [Related]
9. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
10. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model.
Babu A; Jeyasubramanian K; Gunasekaran P; Murugesan R
J Biomed Nanotechnol; 2012 Feb; 8(1):43-56. PubMed ID: 22515093
[TBL] [Abstract][Full Text] [Related]
11. Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
Xu S; Chen S; Zhang M; Shen T; Liu Z; Zhao Y; Wu Y
Anticancer Drug Des; 2001 Dec; 16(6):271-7. PubMed ID: 12375880
[TBL] [Abstract][Full Text] [Related]
12. Hypocrellin B-encapsulated nanoparticle-mediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cells.
Bai D; Xia X; Yow CM; Chu ES; Xu C
Eur J Pharmacol; 2011 Jan; 650(2-3):496-500. PubMed ID: 20970418
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity.
Deng H; Liu X; Xie J; Yin R; Huang N; Gu Y; Zhao J
J Med Chem; 2012 Mar; 55(5):1910-9. PubMed ID: 22352922
[TBL] [Abstract][Full Text] [Related]
14. Uptake kinetics and intracellular localization of hypocrellin photosensitizers for photodynamic therapy: a confocal microscopy study.
Miller GG; Brown K; Moore RB; Diwu ZJ; Liu J; Huang L; Lown JW; Begg DA; Chlumecky V; Tulip J
Photochem Photobiol; 1995 Jun; 61(6):632-8. PubMed ID: 7568409
[TBL] [Abstract][Full Text] [Related]
15. Photo-killing mechanism of 2-demethoxy-2,3-ethylenediamino hypocrellin B (EDAHB) to HeLa cells.
Zhou Z; Li Q; Liu W; Zhang L; Wang X; Ma H; Sheng W; Li Z; Zeng Y; Zhong R
J Photochem Photobiol B; 2012 Dec; 117():47-54. PubMed ID: 23037979
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.
Zhao H; Yin R; Chen D; Ren J; Wang Y; Zhanga J; Deng H; Wang Y; Qiu H; Huang N; Zou Q; Zhao J; Gu Y
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):204-12. PubMed ID: 24534694
[TBL] [Abstract][Full Text] [Related]
17. Investigation of photobleaching of hypocrellin B in non-polar organic solvent and in liposome suspension.
Yu C; Xu S; Chen S; Zhang M; Shen T
J Photochem Photobiol B; 2002 Nov; 68(2-3):73-8. PubMed ID: 12468200
[TBL] [Abstract][Full Text] [Related]
18. Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system.
Li Z; Sun L; Lu Z; Su X; Yang Q; Qu X; Li L; Song K; Kong B
Int J Oncol; 2015 Sep; 47(3):1070-6. PubMed ID: 26165140
[TBL] [Abstract][Full Text] [Related]
19. Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update.
Miller GG; Brown K; Ballangrud AM; Barajas O; Xiao Z; Tulip J; Lown JW; Leithoff JM; Allalunis-Turner MJ; Mehta RD; Moore RB
Photochem Photobiol; 1997 Apr; 65(4):714-22. PubMed ID: 9114749
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B.
Jiang Y; Leung AW; Wang X; Zhang H; Xu C
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):600-6. PubMed ID: 24284117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
